McKesson Corporation (MCK) Stock Analysis — Probabli.AI
AI-powered analysis for MCK (McKesson Corporation): probabilistic price forecasts, technical signals, peer comparison, institutional ownership, earnings history, and social sentiment. Latest AI outlook: Bullish.
Last price: $754.76 · Market cap: $92.5B · AI outlook: Bullish
McKesson Corporation has strong growth potential, supported by its leadership in pharmaceutical distribution and its strategic initiatives in digital health and sustainability. Despite facing challenges such as lawsuits and supply chain issues, the company's solid fundamentals and positive industry outlook suggest above-market returns over medium-to-long-term timeframes.
Probabilistic 1-Year Outlook
- Bull 45% · Neutral 35% · Bear 20%
- 1-year price estimates — P10: $680 / P50: $850 / P90: $1,000
- McKesson Corporation is in a good position for growth given its recent acquisition and telehealth initiatives. However, supply chain issues and legal disputes create downside risks.
5-Year Outlook
- Bull 50% · Neutral 30% · Bear 20%
- 5-year price estimates — P10: $600 / P50: $1,200 / P90: $1,600
SWOT Highlights
- Strength: Market leader in pharmaceutical distribution
- Strength: Strong financial performance with consistent earnings growth
- Risk: Low dividend yield
- Risk: Supply chain vulnerabilities
Major Catalysts
- [object Object]
- [object Object]
- [object Object]
Analyst Coverage & Dividends
14 Wall Street analysts rate MCK a BUY with a mean price target of $952.92. McKesson Corporation currently pays a dividend with a yield of approximately 0.43%.
Last analyzed · Model: gpt-4o. How this forecast works · Accuracy & validation.
MCK forecast details · MCK sentiment details
The information on this page is for educational and informational purposes only and does not constitute professional financial advice.